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AbstrAct
background Liver disease is the third most common 
cause of premature death in the UK. The symptoms of 
terminal liver disease are often difficult to treat, but very 
few patients see a palliative care specialist and a high 
proportion die in hospital. Primary care has been identified 
as a setting where knowledge and awareness of liver 
disease is poor. Little is known about general practitioners’ 
(GPs) perceptions of their role in managing end-stage liver 
disease.
Objective To explore GPs’ experiences and perceptions 
of how primary care can enhance end-of-life care for 
patients with liver disease.
Design Qualitative interview study, thematic analysis.
Participants Purposive sample of 25 GPs from five 
regions of England.
results GPs expressed a desire to be more closely 
involved in end-of-life care for patients with liver disease 
but identified a number of factors that constrained their 
ability to contribute. These fell into three main areas; those 
relating directly to the condition, (symptom management 
and the need to combine a palliative care approach 
with ongoing medical interventions); issues arising from 
patients’ social circumstances (stigma, social isolation and 
the social consequences of liver disease) and deficiencies 
in the organisation and delivery of services. Collaborative 
working with support from specialist hospital clinicians 
was regarded as essential, with GPs acknowledging their 
lack of experience and expertise in this area.
conclusions End-of-life care for patients with liver 
disease merits attention from both primary and secondary 
care services. Development of care pathways and 
equitable access to symptom relief should be a priority.
IntrODuctIOn
End-stage liver disease is an important chal-
lenge for providers of palliative and end-of-life 
care. Death rates have increased 400% since 
1970, and it is now the third most common 
cause of premature death in the UK.1–3 In 
2012, around 11 000 deaths were attributed 
to liver disease in the UK. Patients have a 
complex and heavy symptom burden that is 
often poorly treated4 5 and the psychosocial 
needs of patients and families may be consid-
erable.6 The majority of patients present late 
to services, when liver disease is irreversible 
and around 70% die in hospital.7 The typical 
clinical course, of gradual decline punctuated 
by episodic decompensation, may mean that 
treatment is focused on prolonging life and a 
palliative care approach is rarely considered.8 
Transplantation is an option only for selected 
patients,9 with some evidence suggesting that 
patients who are considered and rejected for 
organ transplantation are unlikely to receive 
any palliative care.10 Research suggests that 
people with liver disease are less likely to 
be involved in end-of-life discussions and 
planning than cancer patients, though data 
are limited.11 Discussing care plans that 
acknowledge the proximity of death is diffi-
cult, particularly when patients are receiving 
interventionist care. However, it is important, 
as timely referral to palliative care can be 
compromised when the focus remains 
inappropriately on treatment with curative 
intent.12
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Research
strengths and limitations of this study
 ► To the best of our knowledge, this is the first study to 
focus on the experiences of primary care clinicians 
around managing end-of-life liver disease.
 ► General practitioners (GPs) were recruited from a 
range of both rural and urban UK locations.
 ► Use of semistructured interviews allowed us to 
collect detailed descriptions of GPs’ experiences of 
managing end-of-life liver disease.
 ► The study was conducted by a team of experienced 
researchers with a range of disciplinary backgrounds 
including clinical experience.
 ► The findings of our study are based on the reported 
knowledge and experiences of self-selecting 
participants, their views may not be transferable to 
the wider GP population.
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There is a growing international consensus that 
end-of-life care for patients with liver disease requires 
improvement.4 11 13 14 Primary care has been identified as 
a specific area where care could be enhanced, particu-
larly around the discussion of palliative care needs with 
patients, the inclusion of patients on palliative care regis-
ters and improving communication between primary and 
secondary care.8 15 Primary care professionals are well 
placed to provide holistic care that patients dying with 
liver disease need but are seldom involved. In addition, 
general practitioner (GP) care for patients dying with 
liver disease is not rated highly by bereaved relatives.8 16
Little is known about how health professionals in 
primary care see their role in end-stage liver disease or 
what they view as the main barriers to providing high 
quality care. This study intends to contribute to our 
understanding of this patient group and to inform the 
development of appropriate services. The aim is to 
explore GPs' experiences and perceptions of end-of-life 
care for patients with liver disease.
MethODs
This study employed qualitative methods, involving semi-
structured interviews with GPs from five geographical 
areas within England.
Participants
A heterogeneous purposive sampling approach was 
employed to ensure that a variety of perspectives and 
experiences of management of liver disease were sampled; 
for example, previous management of an end-of-life liver 
patient, views on whether management should be primary 
care or secondary care led, as well as a range of prac-
tice sizes and localities. Participants were recruited via 
National Institute for Health Research Clinical Research 
Networks (CRN) and local networks of GP practices in 
London, Thames Valley, Wessex, Yorkshire and the North 
East of England. Sampling began with one CRN and was 
expanded during the course of the study to include four 
additional areas. Coordinators at the CRNs were used to 
target practices in a variety of rural and urban locations, 
as well as areas of high and low prevalence of liver disease 
and substance misuse. Email invitations were sent to GP 
practices within these networks, and GPs who wished to 
participate then contacted the research team.
Data collection
A semi-structured interview guide was developed to 
cover issues identified through a review of the literature, 
including GPs’ experiences of identifying and managing 
end-of-life liver disease. This was a ‘living’ document that 
evolved throughout data collection to allow exploration 
of emerging areas. Interviews were conducted face to face 
(n=2) or over the telephone (n=23). Interviews lasted 
between 15 and 50 min and were all conducted by the 
first author between March and August 2016. Field notes 
were taken to aid subsequent analysis. Informed consent 
was obtained from all participants. Data collection ceased 
when no themes were emerging from the interviews (see 
below for further detail).
Data analysis
Audio recordings of interviews were transcribed verbatim 
by an independent transcription company; transcripts 
were checked for accuracy by listening again to each 
recording. The NVivo V.10 software package was used to 
manage the data.
Data collection and analysis ran concurrently 
throughout the study. Analysis of early transcripts 
informed the interview schedule for later interviews and 
each transcript was re-examined in light of subsequent 
interviews. A thematic analysis was conducted.17 The 
first stage involved researchers familiarising themselves 
with the data through detailed reading of the transcripts 
followed by line-by-line coding.18 Field notes taken during 
data collection were used throughout analysis to enhance 
the reflective process. Several quality control measures 
were employed to ensure trustworthiness of the data. A 
proportion of the transcripts (20%) were coded inde-
pendently by three researchers, before coming together 
to compare their analysis. Data analysis and emerging 
themes were also discussed among the wider research 
team, which included individuals with clinical expertise 
in general practice and hepatology.
FInDIngs
Twenty-five GPs were interviewed. The majority had been 
qualified as GPs for 5 or more years, but few (4/25) had 
any specialist hepatology or gastroenterology training 
or experience. Participant characteristics are shown in 
table 1.
Four themes were identified from the data analysis: the 
role of the GP, acknowledging and accepting end of life, 
collaborative care pathways and social relationships and 
consequences. The quotations presented below are illus-
trative, representing typical participant responses and 
demonstrating the varied viewpoints.
the role of the gP
In this study, few of the interviewees had extensive first-
hand experience of managing patients with liver disease 
at the end of life. Those who did, reported that they 
managed such cases infrequently, and some years may go 
by without them seeing a case.
 (We manage) a lot of dying people, but not from the 
hepatology point of view. I don’t know if they tend to 
be managed in hospital predominantly more than in 
primary care? That’s a possibility, I guess. (GP 7)
Some of the interviewees attributed their lack of exper-
tise and experience of caring for liver patients at the end 
of life to a reluctance among hospital clinicians to relin-
quish control.
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Table 1 Participant characteristics
Characteristic Number of GPs
Sex
  Male 12
  Female 13
Years of experience as GP
  <5 years 5
  5–10 years 10
  16–25 years 9
  >25 years 1
Specialist hepatology/gastroenterology 
experience or training
  Yes 4
  No 21
Size of practice (registered patient 
population)
  <5000 5
  5–10 000 9
  10 000–15 000 9
  >15 000 2
Geographical area
  North West London 7
  Wessex 8
  North East and North Cumbria 5
  Yorkshire and Humber 1
  Thames Valley and South Midlands 4
GP, general practitioner.
 There are some conditions, like liver disease, renal 
failure, they [patients[ all just end up dying in 
hospital for some reason. I don’t know whether it’s 
the hospital consultants that don’t want to let them 
go home… They need to let go and make sure there’s 
a palliative care plan in place…they don’t do it. (GP 
3)
The limited contact between GPs and patients dying 
with liver disease was attributed to an unpredictable 
disease trajectory with periods of stability and decompen-
sation and to patients remaining under the care of hospital 
services in their last weeks and months. The GPs in this 
study shared a view that end-of-life care is a core compo-
nent of primary care, and interviewees questioned how 
appropriate it was for specialist hospital clinicians to take 
a lead in palliative care. Patients with liver disease were 
not regarded as distinct or different from patients dying 
with other conditions, and a number of GPs expressed 
a desire for greater involvement in their end-of-life care. 
Some participants implied that primary care involvement 
may support more patients to die at home rather than in 
hospital.
I think primary care probably is best placed, in most 
cases, to look after people- well not only for that [liver 
disease], for most end-of-life care issues. So, yeah, I 
think the GP is probably the most important person 
in the sense that they can bear in mind what the 
specialists have advised, but at the end of the day, try 
and keep some of these patients at home rather than 
having to have them admitted acutely. (GP 14)
Acknowledging and accepting end of life
Judging when a patient with liver disease is nearing the 
end-of-life was perceived to be a particular challenge. 
Communication about prognosis and the age of patients 
were identified as important factors. Some of the GPs 
reflected on how management decisions taken in hospital 
send out messages that influence care provided in the 
community. Continuing to pursue active treatment may 
convey optimism about the patient’s life expectancy. 
Specifically, GPs referenced occasions where patients 
had been placed on the waiting list for a liver transplant, 
which the patient saw as offering them a second chance 
at life even though they were critically unwell and may die 
while waiting for an organ. Patients with end-stage liver 
disease are often younger than the typical palliative care 
patient.19 It may be that clinicians are more reluctant to 
give up on active treatment for younger patients,20while 
patients and families may also struggle to accept that the 
end-of-life is approaching.21
Those patients where it’s a, kind of, grey area about 
whether they’re end-of-life or not. And I think that 
mainly stems from the fact that if it’s a young patient, 
it’s more difficult for healthcare professionals, the 
patients themselves, and families, to actually accept 
that the person’s dying. (GP1)
Mixed or uncertain messages may mean that care is 
compromised, if no one engages the patient in discus-
sions about the end of life, and a palliative approach is 
never considered.
I suppose, looking back it really was palliative care 
but they (secondary care) put him on the transplant 
list because he’s given up alcohol and there was still 
this hope. So therefore we didn’t really realise he was 
going to die as quickly as he did. (GP 11)
There was a shared feeling among interviewees, that 
specialists should provide clear messages about patients’ 
prognoses, so that GPs can adopt an appropriate manage-
ment plan. At present, hospital specialists were perceived as 
failing to take responsibility for identifying patients as end 
of life, and this had a detrimental impact on primary care.
I feel that it should be made compulsory for the 
secondary care, tertiary care sectors, when they 
discharge, or when they’re seen in the patient clinic, 
[to] prognosticate, … then we can initiate also, the 
discussion with the patient, in a much more positive 
way. (GP 12)
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collaborative care pathways
Supporting patients with liver disease was seen as a collab-
orative effort, with GPs acknowledging their need for 
specialist guidance, particularly when managing end-of-
life complications. A small number of respondents 
mentioned hepatic encephalopathy as a challenge in the 
management of end-of-life liver patients and a potential 
source of distress for relatives. The interviewees suggested 
that they would benefit from further training to deal 
with this complication. Ascites was the most commonly 
mentioned symptom experienced by patients with 
end-stage liver disease, requiring drainage in hospital. 
Experiences of GPs in this study suggest that ease of 
access to this procedure was highly variable. In some 
areas, pathways had been negotiated and patients could 
be directly admitted to an appropriate ward. In others, 
GPs described their concern at having to send patients to 
accident and emergency departments. Failure to arrange 
prompt access to treatment caused distress and was a 
major source of adverse experiences during end-of-life 
care.
We had a nightmare. He was building up litres of 
ascitic fluid on his tummy every week or week to 10 
days, and every time the hospital had to send him 
acutely, new, to A&E and he had to sit in A&E for 
hours. I was speaking to the liver specialist. He needed 
regular reviews and eventually they agreed to do it 
2 weekly but even that wasn’t enough, it was building 
up and he was ending up going in as an emergency 
every week. (GP 11)
Where appropriate care pathways were not in place, 
interviewees suggested that they were needed, to reassure 
the patient and GPs that support is available when required.
A number of participants suggested that a specialist 
nurse may hold the key to more collaborative manage-
ment of liver patients. They could act as an intermediary 
between primary and secondary care, negotiating priori-
ties and ensuring effective and easy communication.
It often helps when there is direct access to, say, a 
nurse specialist in a field, or there is some other point 
of contact in secondary care that say a family or the 
patient themselves can call directly for advice. (GP 
14)
Although some GPs had encountered specialist nurses 
working in this type of role, this was not a common expe-
rience. Unfavourable comparisons were made between 
the services available for patients with liver disease and 
other conditions, such as cancer. Participants highlighted 
the potential benefit to patients and families, of having 
a specialist point of contact in the community, including 
prompt access to advice and alleviation of fears and 
concerns.
social relationships and consequences
GPs in this study argued that people with liver disease 
had many of the same primary care needs as patients 
with other life-limiting conditions. However, the severity 
of symptoms in end-of-life liver disease was felt to be 
different. Some of the GPs acknowledged the potentially 
damaging impact on the patient’s family, of seeing their 
relative die at home.
I think there is quite a strong push to keep people at 
home. Whether that’s right or wrong, I don’t know 
really. If they’ve got ascites or portal hypertension, 
you know, they’ve got the risk of vomiting blood and 
all the rest of it. Or they have been vomiting blood. 
I’m not massively keen on keeping people at home 
because it’s just a rubbish picture in the mind of 
everybody, I think, you know, the family left behind. 
(GP 17)
Families were perceived to be in need of support them-
selves, which was an additional role for primary care. 
GPs described examples of relatives requiring frequent 
contact and reassurance as the patient’s condition dete-
riorated. The GPs in this study differed in their attitudes 
towards these demands. Some took a holistic view to the 
management of palliative patients, believing that these 
were part of the standard practice of primary care.
I think when we talk about palliative care it’s not just a 
single person who’s the patient, it’s about supporting 
and managing the family and helping them through 
that bereavement stage because it starts right at the 
diagnosis and they have to go through that journey. 
Death is a part of life and giving them that support. 
(GP 10)
However, others felt that attending to the needs of 
patients’ families was an extra burden on their already 
overstretched resources.
Limited social support and unfavourable social circum-
stances were often mentioned as significant issues for 
patients with liver disease, particularly when alcohol or 
drug misuse were factors. Several GPs referred to the 
‘chaotic’ lifestyles of this patient group and resulting 
vulnerability to social isolation. Behaviours associated 
with addiction were perceived to lead to the breakdown 
of the patients’ social networks, leaving few, if any people 
to provide support or care.
The demographics of the alcohol dependent ones, 
who have often, for various reasons and due to the 
nature of their disease, have become quite isolated, 
they have not got many people around them and 
so they don’t have that support. They require much 
more organisation and support in the background, 
so we make sure that they do have that support. (GP 
10)
Without alternative sources of support, socially isolated 
patients were believed to place extra demands on GPs 
and other health services. Even when social networks 
were maintained, there could be a dearth of responsible 
caregivers, as friends and family often shared the prob-
lems of addiction and poor health.
group.bmj.com on September 20, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 5Standing H, et al. BMJ Open 2017;7:e017106. doi:10.1136/bmjopen-2017-017106
Open Access
I can think of a couple of our households where 
maybe spouses and partners may have liver cirrhosis 
themselves. I can think of two couples—well, one 
person who died 2 years ago. His wife has chronic 
liver disease as well. (GP 4)
One of the most important consequences of social isola-
tion was that patients had fewer choices over where they 
spent the end of their life. Without anyone to monitor 
their condition, they were more likely to be admitted to 
hospital and die there.
Liver disease is a potentially stigmatising condition, 
particularly when the underlying cause is alcohol or 
substance misuse. Several of the GPs suggested that there 
is often an assumption within the patient’s community 
that liver disease is self-induced and they were culpable, 
even when substance misuse or alcohol are not factors.
I think it’s a huge problem for people that have liver 
disease and look like they have liver disease and 
people assume it’s related to alcohol when, in fact, it 
might be due to auto-immune causes or other forms 
of cancer or something like that or hepatitis as well. 
(GP 23)
This assumed culpability has implications for the degree 
of support and sympathy that the patient and their fami-
lies receive. GPs also suggested that stigma could hinder 
patients’ acceptance of their prognosis, which in turn 
made the management of their condition more chal-
lenging. As such, care of liver patients should include 
psychological and social services.
I think, inevitably and sadly, there is a stigma 
associated with liver disease, and hence, that’s why 
the psychological support is really important. (GP 25)
However, some commented that stigmatisation 
occurred early in the patients’ illnesses, and to address 
this, changes would be needed well before end-of-life care 
was being considered.
DIscussIOn
This study provides insights into the challenges faced 
by general practitioners providing end-of-life care for 
patients with chronic liver disease. Many GPs expressed a 
desire to be more closely involved but identified a number 
of factors that constrained their ability to contribute. 
These fell into three main areas: those relating directly 
to the condition, (symptom management and the need 
to combine a palliative care approach with ongoing 
medical interventions); issues arising from patients’ 
social circumstances (stigma, social isolation and the 
social consequences of liver disease) and deficiencies in 
the organisation and delivery of services. Collaborative 
working with support from specialist hospital clinicians 
was regarded as essential, with GPs acknowledging their 
own lack of experience and expertise in this area.
A majority of interviewees had little direct experience 
of patients dying of liver disease and as a consequence, 
they may not have been familiar with all the manage-
ment challenges of end-stage liver disease. For example, 
hepatic encephalopathy is a common concern in the care 
of end-stage liver patients, yet few of the interviewees 
discussed it. This is not surprising, as primary care clini-
cians would seldom have responsibility for managing 
hepatic encephalopathy if they are not dealing day to day 
with end-of-life care for liver disease patients.
strengths and limitations
To our knowledge, this is the first study to focus on the 
experiences of primary care physicians in managing 
patients with end-stage liver disease. Our interviewees 
were drawn from rural and urban areas in five different 
regions in England and working with a diverse range of 
communities. The relatively large number of GP partic-
ipants and varying levels of experience, expertise and 
interest in the subject is a particular strength of the study. 
With our qualitative design, we were not seeking general-
isability, but the diversity of the participants increases our 
confidence that we have not overlooked important issues.
The majority of interviews were conducted by tele-
phone, which may explain the ease and speed with which 
we recruited participants, despite not offering any finan-
cial incentives. Use of the telephone is thought to have 
promoted unguarded responses, but we acknowledge 
that it can be more difficult to develop rapport in the 
absence of non-verbal cues and other facets of face-to-face 
communication. However, we do not believe that this was 
a limitation, as GPs provided rich and insightful accounts 
of their experiences.
Comparison with other work
Our findings are consistent with recent research from 
Scotland that included interviews with eight GPs along 
with other healthcare professionals. Communication with 
secondary care, lack of expertise and limited confidence 
in prognostication were all identified as concerns.15 Accu-
rate assessment of prognosis in liver disease is difficult 
given the unpredictable disease course. In some aspects, 
this is similar to other diseases characterised by episodes 
of decompensation, such as heart failure. However, liver 
disease presents the additional challenge that recompen-
sation and improved liver function may be achieved in 
certain patients, such as those who achieve abstinence 
from alcohol. A recent review of palliative care guide-
lines in heart failure and chronic obstructive pulmonary 
disease described wide variation in how patients are iden-
tified for palliative care, and attributed this, in part, to the 
unpredictable disease course and the consequences for 
care planning.22 In common with liver disease, acknowl-
edgement and development of end-of-life care has been 
relatively recent for these conditions.22
The GPs in our study agreed that, at the end of life, 
patients with liver disease ideally need primary care and 
hospital specialists to work closely together. GPs are more 
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box 1 next steps in primary end-of-life care for liver 
disease: general practitioner perceptions of areas for 
development
 ► Education and training in symptom management for end-stage liver 
disease.
 ► Collaborative care pathways between primary care and 
hepatologists.
 ► Service delivery that takes into account patient and family social 
circumstances and stigma.
 ► Provision of support for family caregivers.
 ► Consideration/research into the role of home death.
likely to have an established relationship with the patient 
and a greater understanding of their social situation and 
needs, whereas specialists offer expert knowledge on 
liver disease and treatment options. They highlighted 
the importance that primary care physicians place on 
being able to provide a coordinating role but only when 
supported by members of the specialist teams. Managing 
complex and unusual symptoms, or judging when to 
introduce a palliative care approach, for example, all 
benefit from collaboration. The advantages of a multidis-
ciplinary approach have already been well documented 
in the palliative care literature.23 24 Several recent reviews 
on end-stage liver disease have also advocated this 
approach.4 5 14
This study highlights the complexity of caring for patients 
with end-stage liver disease. Expertise in acute medicine and 
palliative care are essential, but patients and families also 
need sensitive and practical responses to their psycho-emo-
tional and social concerns, including stigma related to the 
perceived self-inflictedness of the disease, social isolation 
and lack of income. Such generalist expertise and a holistic, 
person-centred approach are the foundations of primary 
care. Community-based services already play an important 
role at the end-of-life for patients with many different, 
complex conditions. However, this seldom includes people 
dying with liver disease. Greater involvement of commu-
nity services would be expected to enhance the quality 
and appropriateness of palliative and terminal care for 
these patients. As the number of deaths from chronic liver 
disease increases, it may be increasingly necessary to limit 
the burden on hospital teams. Innovations, such as the 
development of clear patient pathways, specialist heptology 
nurses in the community or district nurses trained to deal 
with liver disease complications, all require resources. 
Specialist treatments such as paracentesis could be deliv-
ered in locations such as community hospitals or hospices, 
where they are available, to reduce disruption to patients’ 
lives. See Box 1 for a summary of GPs' perceptions of areas 
for development.
In recent years, UK health policy has increasingly 
promoted patient choice, an ability to deliver end-of-
life care in the patient’s preferred location and facilitate 
choice in place of death are used as markers of care quality, 
with death at home often an implicit goal of palliative 
care.25 26 GPs in this study expressed some scepticism that 
home death is always the best option for patients with 
liver disease or their families. Concerns centred around 
the nature of the symptoms and clinical input needed to 
manage them, which were potentially distressing for fami-
lies to observe. Balancing the wishes of patients, families 
and clinical carers is a fundamental part of end of life 
care. More in-depth enquiry to elicit patient, family and 
professional views and experiences of place of death in 
liver disease would help to clarify the resources required 
to ensure death at home is acceptable and achievable.
cOnclusIOn
Our study suggests that end-of-life care for patients with 
liver disease requires attention. Liver disease appears to 
pose management challenges in end-of-life care with a 
combination of complicated social situations and symp-
toms. Services tailored for these patients should build on 
the similarities with other conditions but also reflect the 
differences. The adverse social consequences of illness for 
these patients and their families may be particularly signif-
icant. Further research is needed to fully understand the 
burden on families and services. As health services seek 
greater integration with social care, improving care for 
patients with end-stage liver disease should be a priority.
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